| JEMWX | VEMRX | JEMWX / VEMRX | |
| Total Expense Ratio | 0.74 | 0.05 | 1,480% |
| Annual Report Gross Expense Ratio | 0.81 | 0.05 | 1,620% |
| Fund Existence | 12 years | 15 years | - |
| Gain YTD | 30.554 | 8.650 | 353% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 15000000 | 100000000 | 15% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 10.8B | 163B | 7% |
| Annual Yield % from dividends | 1.06 | 2.43 | 44% |
| Returns for 1 year | 61.21 | 23.66 | 259% |
| Returns for 3 years | 95.09 | 53.96 | 176% |
| Returns for 5 years | 27.85 | 18.32 | 152% |
| Returns for 10 years | 189.85 | 98.02 | 194% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RYOAX | 61.37 | -0.94 | -1.51% |
| Rydex Biotechnology H | |||
| MXNSX | 22.84 | -0.42 | -1.81% |
| Empower S&P SmallCap 600® Index L | |||
| MSTSX | 11.57 | -0.23 | -1.95% |
| Morningstar Global Opportunistic Equity | |||
| WTRCX | 11.52 | -0.35 | -2.95% |
| Nomura Core Equity Fund Class C | |||
| RNGBX | 70.28 | -3.39 | -4.60% |
| American Funds New Economy R2 | |||